Recombinant renewable polyclonal antibodies-Reference-Cited by-同舟云学术

Recombinant renewable polyclonal antibodies

Published:2015-01-02 Issue:1 Volume:7 Page:32-41
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Ferrara Fortunato¹,D’Angelo Sara¹,Gaiotto Tiziano¹²,Naranjo Leslie³,Tian Hongzhao³,Gräslund Susanne⁴,Dobrovetsky Elena⁴,Hraber Peter³,Lund-Johansen Fridtjof⁵,Saragozza Silvia⁶,Sblattero Daniele⁶,Kiss Csaba³,Bradbury Andrew RM³

Affiliation:

1. New Mexico Consortium; Los Alamos, NM USA

2. Present address: National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire, UK

3. Los Alamos National Laboratory; Los Alamos, NM USA

4. Structural Genomics Consortium, University of Toronto, Toronto, ON Canada

5. University of Oslo; Oslo, Norway

6. Università del Piemonte Orientale; Novara, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/19420862.2015.989047

Reference40 articles.

1. Towards a human proteome atlas: High-throughput generation of mono-specific antibodies for tissue profiling

2. Antibody validation

3. A Guide to the Perplexed on the Specificity of Antibodies

4. Commercial Antibodies: The Good, Bad, and Really Ugly

5. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability;mAbs;2024-08-27

2. Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential;PLOS ONE;2024-07-02

3. Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile;Protein Science;2024-06-26

4. Direct selection of functional fluorescent-protein antibody fusions by yeast display;PLOS ONE;2023-02-24

5. A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies;Nature Communications;2022-01-24